Pierre, Fabre

Pierre Fabre Laboratories reciben una opinión positiva del CHMP Por OBGEMSA™ en el síndrome de vejiga hiperactiva.

Published on 08/07/2025 at 18:04 | prnewswire.co.uk

Pierre Fabre United States of America Canada France Germany Spain United Kingdom New Jersey

View original content:https://www.prnewswire.com/news-releases/pierre-fabre-laboratories-reciben-una-opinion-positiva-del-chmp-por-obgemsavibegron-en-el-sindrome-de-vejiga-hiperactiva-302128815.html

en | boerse | 67978435 |